AIFA Authorization

ADIENNE is very pleased to announce that, on April 5th 2022, AIFA authorized the ADIENNE’s manufacturing site in Caponago (MB – Italy) for commercial aseptic productions of:

1) Large Volume Liquids

2) Lyophilized: Special Requirements Cytotoxic Products, Cytostatics

3) Small Volume Liquids

This authorization will allow ADIENNE to start the manufacturing activities for commercial batched of its products in dual-chamber bags for its product TEPADINA 400mg and 200mg; it also opens new market horizons with the other products in our and CDMO pipe-lines.

Recombinant proteins

related news & insights.